Literature DB >> 15581991

Aggressive angiomyxoma of the vulva.

R Ribaldone1, P Piantanida, D Surico, R Boldorini, N Colombo, N Surico.   

Abstract

BACKGROUND: Aggressive angiomyxoma is a rare soft tissue tumour that carries a high risk of local relapse. It is a slowly growing and locally infiltrating tumour. CASE: We describe the case of an aggressive pelvic-perineal angiomyxoma arising in a 36-year-old woman. The patient had a mass that grew before, during and after her pregnancy. Transperineal surgery was performed. The resection margins were free of disease.
CONCLUSION: Our case confirms what has previously been published concerning the possible hormone-dependence of this neoplasm. Given the positive estrogen and progesterone receptor status of this tumour, we will consider hormonal treatments in the case of a future relapse.

Entities:  

Mesh:

Year:  2004        PMID: 15581991     DOI: 10.1016/j.ygyno.2004.07.051

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  A case of aggressive angiomyxoma of the vulva.

Authors:  Hajime Ota; Katsufumi Otsuki; Mitsuyoshi Ichihara; Tetsuya Ishikawa; Takashi Okai
Journal:  J Med Ultrason (2001)       Date:  2013-01-11       Impact factor: 1.314

2.  Angiomyxomatous polyp of vulva.

Authors:  Kiran Pandey; Anshu Mishra; Sonal Jain; Amita Sharma
Journal:  J Obstet Gynaecol India       Date:  2012-10-03

3.  Aggressive angiomyxoma: an unusual presentation.

Authors:  Junzu Geng; Bofeng Cao; Liping Wang
Journal:  Korean J Radiol       Date:  2011-12-23       Impact factor: 3.500

4.  A Case Report of Aggressive Angiomyxoma in Pregnancy: Do Hormones Play a Role?

Authors:  Theofano Orfanelli; Chi-Son Kim; Sally F Vitez; James Van Gurp; Neeti Misra
Journal:  Case Rep Obstet Gynecol       Date:  2016-11-15

5.  Vulval Aggressive Angiomyxoma in a 19 year teenager: a case report.

Authors:  Vitasta Muskan; Purbesh Adhikari; Baburam Dixit Thapa; Ramesh Shrestha
Journal:  BMC Womens Health       Date:  2022-09-19       Impact factor: 2.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.